Review in Journal of bacteriology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
3 authors.
Jazmine A SnowMolecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, USA.ORCID 0009-0009-6108-5195
Stavroula K HatziosDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut, USA.ORCID 0000-0001-8658-8949
Nina R SalamaHuman Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.ORCID 0000-0003-2762-1424
Funding
GENETIC REQUIREMENTS OF HELICOBACTER PYLORI INFECTIONR01AI054423 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Nina Salama · 2004 to 2026
$9.5M
Understanding redox-regulated mechanisms of environmental adaptation in gastrointestinal symbiontsR35GM137952 · NIGMS · YALE UNIVERSITY · PI Stavroula Hatzios · 2020 to 2026
$3.1M
Elucidation of a bacterial cell shape generating program and pathogenic functionsR01AI094839 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SALAMA, NINA · 2012 to 2016
$2.1M
Chemoproteomic discovery and functional characterization of infection-induced oxidation sitesR01AI182086 · NIAID · YALE UNIVERSITY · PI Stavroula Hatzios · 2024 to 2026
$2.1M
Diversity and modularity of innate immune responses to H. pyloriR21AI135381 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SALAMA, NINA · 2018 to 2019
$484k
Gastrointestinal microbiota interactions modulating gastric cancer progressionR21CA270512 · NCI · FRED HUTCHINSON CANCER CENTER · PI SALAMA, NINA · 2022 to 2023
$443k
National Institute of Allergy and Infectious Diseases R01AI054423National Institute of Allergy and Infectious Diseases R01AI136946National Institute of Allergy and Infectious Diseases R01AI182086NCI NIH HHS R21CA270512NIAID NIH HHS R01 AI054423NIAID NIH HHS R01 AI094839NIAID NIH HHS R01 AI182086NIAID NIH HHS R21 AI135381NIGMS NIH HHS R35 GM137952NIGMS NIH HHS R35GM137952
6 · The paper itself
Abstract
As the first bacterium to be deemed a class I carcinogen by the World Health Organization in 1994,
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Managing dangerous liaisons: lessons from · full record | OpenQuestion